On the one hand, KYNA activates G protein-coupled receptor 35 (GPR35) in the intestinal wall, which may exacerbate chronic stress and DSS-induced intestinal inflammation by affecting nod-like receptor protein 3 (NLRP3) [94]. Here, GPR35 is linked to gastroenteritis.